Dr. R Ananthanarayanan appointed as the new CEO & Managing Director of Strides

Ahmedabad (Newswire India) –Strides Pharma Science Limited (Strides) today announced that the Board of Directors (Board) of the Company have appointed Dr. R Ananthanarayanan as Chief Executive Officer (CEO) and Managing Director (MD) of Strides effective January 09, 2020.

Dr. R Ananthanarayanan (Ananth) will succeed Arun Kumar, Founder, and the incumbent CEO &MD of the Company. Arun will transition his active responsibilities at Strides by the financial year ending March 31,2020, and will step into a strategic role as Chairman of the Board with effect from April 01, 2020.

Ananth brings with him over three decades of top pedigree global pharmaceutical experience across both the technical and commercial functions. Until recently, Ananth was the Global Chief Operating Officer at Cipla Limited, where he was responsible for the company’s generics business in regulated markets and branded generics in emerging markets. He was also driving their API business, biosimilars, complex drug-device combinations, including 505(b)(2) products.

Prior to Cipla, Ananth was the President & CEO ofGlobal APIs, Biologics, &Medis Generics B2B division at Teva Pharmaceutical Industries Ltd in the US,managing multi-billion P&L responsibility.He has also held leadership roles at Dr. Reddy’s Laboratories, Piramal Healthcare (Formerly Nicholas Piramal), Galpharm International, UK (Acquired by Perrigo Group), and Zydus Cadila.

Ananth is a Graduate in Pharmaceutical Sciences and earned his Ph.D. in Pharmaceutical Technology from the University of Mumbai, India. He hasalso been a member of the Board of Advisors at the School of Pharmacy and Health Sciences at Fairleigh Dickinson University, New Jersey.

Ananth’s appointment at Strides comes at the time when the company has concluded its reset strategy to drive profitable future growth on the back of a stronger balance sheet. The Board strongly believes that Ananth’s exceptional global techno-commercial experience and leadership stature in managing the P&Ls of large global pharmaceutical companies will multiply the company’s commitment to creating perpetual value for all its stakeholders.

Expressing confidence in the Board’s choice , Arun Kumar, remarked, “Having founded Strides and led the company for close to 30 years, I believe the time is right for me to step aside and have Ananth lead it to greater heights. Ananth brings in the right balance of technical and commercial expertise, and I am confident that Strides will significantly benefit from his leadership experience, industry perspective, technical knowledge, and business acumen. As he takes on the mantle of Strides, I will now move to a more strategic role as the Chairman of the Board and will dedicate time to Strides’ newly announced investments in Biotech and sterile injectables.” 

Dr. R Ananthanarayanan,the new CEO & MD of Strides, commented, “It’s my privilege and honor to take over as the CEO &MD of Strides, and I would like to appreciate the confidence reposed in me by Arun and the Board. These are exciting times for Strides, and I look forward to partner with all the global colleagues to ensure successful realization of the Stridesstrategic objectives while ensuring that we consistently deliver quality medicines to all our patients globally.”

Comments are closed.

Business News Finance PNN News Press Release

Teerth Gopicon Ltd’s Rs. 44.40 crore public issue subscribed over 74 times; Receives overwhelming response

Ahmedabad (Gujarat) [India], April 10:  The initial public offering of Ahmedabad-based Teerth Gopicon Ltd, company specializes in engineering construction and development received overwhelming response for its Rs. 44.40 crore SME IPO and got subscribed over 74.17 times. Non institutional investor category received the highest interest among investors and was subscribed over 97 times. Retail segment […]

Read More
Alt Investment Alternative fixed income alternative Investment Business News Finance GNPA. PNN News Press Release unlisted corporate bonds

altGraaf Crosses 3300 Plus Crore Investments Offering Alternative Fixed Income Opportunities

1,85,000 registered investors drive ~150% volume growth in FY24 Bengaluru (Karnataka) [India], April 8: altGraaf, an alternative fixed-income platform offering fixed-income products, today announced a milestone achievement of 3300+ crores of investments from more than 1,85,000 registered investors, crediting their success to their valuable customers, partners and clients. The 3300+ crore investments represent a 153% volume […]

Read More
Business News Finance PNN News Press Release

Teerth Gopicon plans to raise up to Rs. 44.40 crore from public issue; IPO opens April 8

Ahmedabad (Gujarat) [India], April 8:  Ahmedabad based Teerth Gopicon Ltd, company specializes in engineering construction and development mainly focusing on roads, sewerage and water distribution projects is planning to raise up to Rs. 44.40 crore from its SME public issue. The company has received approval to launch its public issue on NSE Emerge Platform of […]

Read More